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Abstract
In this paper we describe the phosphine-catalyzed [3 + 2], [3 + 3], [4 + 3], and [3 + 2 + 3]
annulations of azomethine imines and allenoates. These processes mark the first use of azomethine
imines in nucleophilic phosphine catalysis, producing dinitrogen-fused heterocycles, including
tetrahydropyrazolo-pyrazolones, -pyridazinones, -diazepinones, and -diazocinones. Counting the
two different reaction modes in the [3 + 3] cyclizations, there are five distinct reaction pathways—
the choice of which depends on the structure and chemical properties of the allenoate. All
reactions are operationally simple and proceed smoothly under mild reaction conditions, affording
a broad range of 1,2-dinitrogen–containing heterocycles in moderate to excellent yields. A
zwitterionic intermediate formed from a phosphine and two molecules of ethyl 2,3-butadienoate
acted as a 1,5-dipole in the annulations of azomethine imines, leading to the [3 + 2 + 3]
tetrahydropyrazolodiazocinone products. The incorporation of two molecules of an allenoate into
an eight-membered-ring product represents a new application of this versatile class of molecules
in nucleophilic phosphine catalysis. The salient features of this protocol—the facile access to a
diverse range of nitrogen-containing heterocycles and the simple preparation of azomethine imine
substrates—suggest that it might find extensive applications in heterocycle synthesis.
Introduction
Intermolecular cycloaddition is one of the most powerful tools for the convergent synthesis
of a variety of carbo- and heterocycles from simpler precursors.1 Many metallo- and
organocatalytic systems have been successfully developed for the cycloadditions of a wide
range of starting materials. Among the catalytic systems, nucleophilic phosphine catalysis
has been established as a reliable platform for the efficient assembly of a wide array of
cyclic products from simple building blocks.2 In particular, activated allenes subjected to
nucleophilic phosphine catalysis conditions exhibit superbly diverse reactivity toward
electrophilic reagents. These allenes can function as one-, two-, three-, or four-carbon
synthons when reacting with a variety of electrophilic coupling partners (including
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aldehydes, alkenes, imines, and aziridines), undergoing [2 + 1],3 [4 + 1],4 [3 + 2],5 [2 + 2 +
2],6 [3 + 3],7 [4 + 2],8 [4 + 3]9, or [8 + 2]10 annulations.11 The particular reactivity of the
allene substrate is often induced by its electrophilic coupling partner. Consequently, the
search for new electrophilic substrates exhibiting suitable reactivity for effective use in the
synthesis of heterocycles with new skeletons or structural features is a major challenge for
the formation of diverse cycloaddition products from the nucleophilic phosphine catalysis of
allenes. In this context, we conceived the possibility of introducing a new type of
electrophilic coupling reagent, azomethine imines, that might serve as an N–N–C trio-of-
atoms synthon in phosphine-catalyzed annulation processes. Herein, we report the
phosphine-catalyzed [3 + N] annulations of allenoates and azomethine imines 1 (Scheme 1).
Azomethine imines such as 1 are readily accessible, stable compounds that have been
employed recently as efficient 1,3-dipoles in various metal-catalyzed and organocatalytic
cycloadditions.12–14 In 2003, Fu reported an efficient Cu-catalyzed protocol for
enantioselective [3 + 2] cycloaddition of azomethine imines with alkynes;14a in 2005, he
further extended this azomethine imine/alkyne cycloaddition strategy to the kinetic
resolution of azomethine imines bearing a stereocenter at the 5-position of the
pyrazolidinone core.14b Sibi demonstrated another Cu-catalyzed enantioselective [3 + 2]
cycloaddition of azomethine imines with pyrazolidinone acrylates.14i Pale and Sommer
presented a heterogeneous Cu(I)-modified zeolite-catalyzed [3 + 2] cycloaddition of
azomethine imines with alkynes.14k Hayashi studied Pd-catalyzed [3 + 3] cycloadditions of
azomethine imines with trimethylenemethane to produce hexahydropyridazine derivatives
under mild conditions,14c and Pd-catalyzed [4 + 3] cycloadditions of azomethine imines
with γ-methylidene-δ-valerolactones.14g Toste reported a Au-catalyzed [3 + 3] annulation of
azomethine imines with propargyl esters.14j Maruoka developed a Ti-catalyzed
enantioselective [3 + 2] cycloaddition of azomethine imines with α,β-unsaturated
aldehydes.14m Suga described a Ni-catalyzed enantioselective and diastereoselective [3 + 2]
cycloaddition of azomethine imines with 3-acryloyl-2-oxazolidinone.14f Charette also
developed a Ni-catalyzed [3 + 3] cycloaddition of aromatic azomethine imines with 1,1-
cyclopropane diesters.14l More recently, Scheidt described an N-heterocyclic carbene-
catalyzed stereoselective formal [3 + 3] cycloaddition of azomethine imines with enals.14e
Chen developed a multifunctional primary amine (derived from cinchona alkaloids)–
catalyzed enantioselective [3 + 2] cycloaddition of azomethine imines and cyclic enones,14h
and a diarylprolinol salt–catalyzed [3 + 2] cycloaddition of azomethine imines with α,β-
unsaturated aldehydes.14d Despite these extensive efforts at using azomethine imines as
cyclization partners in heterocycle synthesis, the application of azomethine imines in
phosphine-catalyzed cycloaddition has not been reported previously. This situation
prompted us to design a cycloaddition of azomethine imines and allenoates using readily
available tertiary phosphines as catalysts. It is widely accepted that, in the phosphine-
promoted reactions of activated allenoates, the catalysis cycle is typically initiated by the
addition of the Lewis basic phosphine to the electrophilic β-carbon atom of the α-allenic
ester, leading to the formation of zwitterionic intermediates. We suspected that exposing
these intermediates to azomethine imines might allow new [3 + N] cycloadditions, with the
pathways followed depending on the number of carbon atoms that the allenoate contributes
to the final cyclic products (Scheme 1). Herein, we report the first examples of phosphine-
catalyzed cycloadditions of various zwitterionic species to provide functionalized five-, six-,
seven-, and eight-membered dinitrogen-containing heterocycles with high efficiency.
The new annulation reactions provide generally applicable routes toward dinitrogen-fused
heterocycles, including tetrahydropyrazolo-pyrazolones, -pyridazinones, -diazepinones, and
-diazocinones, which are key units in or building blocks of many pharmaceuticals,
agrochemicals, biologically active compounds, and other useful chemicals. Among the
dinitrogen-containing heterocycles, pyrazolone derivatives are often used as dyes in the
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food, textile, photography, and cosmetics industries.15 Several pyrazolones also exhibit
bioactivity. For example, phenazone has been used as a synthetic drug;16 phenylbutazone
has anti-inflammatory activity;16 phenidone and BW755C are inhibitors of lipoxygenase and
cyclooxygenase, respectively;17,18 BW357U displays anorectic activity (Figure 1).19 Other
dinitrogen-fused heterocycles also exhibit diverse bioactivity and have a variety of
applications. Tetrahydropyrazolopyrazolones have been investigated as antibacterial
agents,16 herbicides, pesticides,20 antitumor agents,21 calcitonin agonists,22 and potent drugs
to relieve Alzheimer’s disease.23 Pyrazolopyridazinone derivatives have been studied
extensively as pesticides and, especially, herbicides; more than 60 patents have been filed
according to the CAS database. Pyrazolodiazepinone and pyrazolodiazocinone derivatives
have also been explored as herbicides, insecticides, acaricides,24 and acetyl-CoA
carboxylase inhibitors.25 In addition, the pyrazolidine derivatives obtained through these
annulations are readily transformed into 1,3-diamine derivatives via N–N bond cleavage
with SmI2;26 this cleavage strategy has been demonstrated in several reports.14j,27 Such 1,3-
diamine derivatives serve not only as ligands of metal catalysts but also as biologically
important compounds or building blocks for bioactive compounds.28
Results and Discussion
Although the azomethine imines 1 have received much attention,14 including extensive
application in 1,3-diploar cycloadditions for the preparation of a plethora of pyrazolidinone
derivatives,29 they have never previously been used in nucleophilic phosphine catalysis
reactions. Our initial attempts at phosphine-catalyzed annulations of azomethine imines
commenced with the reactions of 1-(p-nitrobenzylidene)-3-oxopyrazolidin-1-ium-2-ide (1a).
Table 1 presents the results of screening for appropriate reaction conditions and catalysts for
the model reaction between 1a and allenoate 2a. Considering the possibility of a background
reaction resulting from direct [3 + 2] cycloaddition of the azomethine imine and the
allenoate,30 we first attempted the reaction between 1a and the allenoate 2a in the absence of
phosphine catalyst in dichloromethane (DCM) at room temperature; TLC analysis revealed
no product (Table 1, entry 1). When compound 1a was treated with ethyl 2-methyl-buta-2,3-
dienoate (2a) in DCM31 at room temperature in the presence of 20 mol % of PPh3, we
isolated a new product in 5% yield (Table 1, entry 2). The efficiency of nucleophilic
phosphine catalysis often depends on the nature of the tertiary phosphine catalyst; α-alkyl
allenoates, such as 2a, often require more-nucleophilic phosphines for facile reactions.8a,b
Indeed, screening of a couple of tertiary phosphines for the catalysis revealed that the
reaction efficiency increased as the nucleophilicity of the phosphine increased, reaching
92% product yield for PMe3 (entries 3–6). Using NMR spectroscopy and X-ray
crystallography of the homologous tetrahydropyrazolopyrazolone 3ad obtained from the
annulation of 1a with the α-isobutyl allenoate 2d, we established the structure of the new
annulation product 3aa to be that from a [3 + 2] cycloaddition. Not only did the [3 + 2]
annulation exhibit great efficiency, it also provided the tetrasubstituted exocyclic alkylidene
as a single E isomer. Hexamethylphosphorous triamide (HMPT), albeit more nucleophilic
than PPh3, did not provide any desired product (entry 7).
A large number of phosphine-catalyzed annulations have been rendered enantioselective
through the use of enantioenriched chiral phosphines.2k To gauge the feasibility of
developing enantioselective azomethine imine annulation, we tested the effect of 10 known
chiral phosphines (Table 2). DiPAMP, BINAP, Me-DuPhos, TangPhos, Et-BINEPINE, t-
Bu-BINEPINE, and FerroPHANE were poor catalysts and provided negligible amounts of
products, even after reaction times of five days (entries 1–3 and 5–8). Et-BPE provided the
desired tetrahydropyrazolopyrazolone 3ba in 19% yield and 6% ee (entry 4). To our delight,
the chiral monophosphines I and II rendered high enantiomeric excesses with a synthetically
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useful yield in the case of II (entries 9 and 10), demonstrating the feasibility of developing
an enantioselective process of synthetic value.
Using 20 mol % of PBu3 as the catalyst, we examined a range of azomethine imines in the
[3 + 2] annulations of ethyl 2-methyl-buta-2,3-dienoate (2a) under the optimized reaction
conditions (Table 3). Here, we employed PBu3 instead of PMe3 for ease of operation; the
reactions of the azomethine imines 1b–1u with the allenoate 2a were also highly efficient
(up to 99% yield) when mediated by PBu3. A variety of aryl azomethine imines underwent
the [3 + 2] cycloaddition, providing the anticipated tetrahydropyrazolopyrazolones in
moderate to excellent yields (entries 1–17). In general, azomethine imines bearing electron-
withdrawing groups on the benzene ring provided somewhat higher yields of the cyclization
products than did those bearing electron-donating groups (cf. entries 2–4 and 5–11). The
reactions employing azomethine imines containing ortho-substituted benzene rings required
elevated temperatures and longer times and furnished the tetrahydropyrazolopyrazolones in
modest yields (entries 12–14). The azomethine imines bearing 2-naphthyl, 4-pyridyl, and 2-
furyl groups, also underwent smooth cyclizations with 2a, readily affording the
corresponding pyrazolidinone derivatives in excellent yields (entries 15–17). We were
delighted to find that even alkylimines could be employed in [3 + 2] annulations with the
allenoate 2a, albeit in moderate yields (entries 18–20).
Next, we investigated the reactions of a range of distinctly substituted allenoates 2 with the
azomethine imine 1a in the presence of 20 mol % of PMe3 (Table 4). For the sterically more
demanding allenoates 2b–2m, we employed the more-reactive PMe3 as the catalyst. Based
on the proposed reaction mechanism (vide infra), we did not anticipate the substituent at the
β′-carbon atom of the allenoate 2 to exert much influence on the course of the reaction. A
variety of β′-alkyl– and β′-aryl–substituted allenoates underwent the cycloaddition at
reasonable rates, providing the corresponding tetrahydropyrazolopyrazolones 3 in excellent
yields (entries 1–11). In general, alkyl-substituted allenoates required a slightly elevated
temperature (40 °C) for the reaction to proceed at a reasonable rate (entries 2–5). Allenoates
featuring phenyl groups with either electron-withdrawing or -donating substituents worked
very well as substrates at room temperature (entries 6–11). In contrast, the reactions of β′-
vinyl– and β′-styryl–substituted allenoates were somewhat sluggish, providing their
corresponding products in moderate yields even after prolonged reaction times (entries 12
and 13).
In contrast to the aforementioned cases wherein excellent selectivity was observed, the
reaction involving diethyl 2-vinylidenesuccinate (2n) was more complicated and seemed to
follow several competing pathways. Under conditions otherwise identical to those described
above, 2n underwent the PBu3-mediated cycloaddition with the azomethine imine 1a in a
distinctive manner: a combination of [3 + 2], [3 + 3], and [3 + 4] reactions, affording a
mixture of the tetrahydropyrazolopyrazolone 3an, the tetrahydropyrazolopyridazinone 4,
and the tetrahydropyrazolodiazepinone 5 in 6, 23, and 63% (trans- and cis-5) yields,
respectively (Scheme 2). Intriguingly, the use of PMe3 as the catalyst afforded strikingly
different results. The [3 + 2] product 3an and the [3 + 3] product 4 were obtained in 40 and
42% yields, respectively, while the [4 + 3] product 5 was isolated in only 12% yield (trans-
and cis-5). We used single-crystal X-ray analyses to unequivocally verify the structures of
the annulation products 3an, 4, and trans-5. In an effort to force the reaction to follow one
of the cycloaddition modes preferentially, we screened phosphines with various
nucleophilicities under a range of reaction conditions (solvents, temperatures, other
controllable factors), but we always obtained mixtures of several cycloaddition products. We
also investigated the reactions of other azomethine imines with the allenoate 2n, but, in
general, they invariably produced more than two products, including those from [3 + 2], [3 +
3], and [4 + 3] cycloadditions. Although the [3 + 3] annulation mode had been observed
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previously for diethyl 2-vinylidenesuccinate (2n) in its phosphine-mediated annulation with
aziridines,7 the [4 + 3] annulation modality had not. The distinctive behavior of the diester
allenoate 2n relative to those of the other α-alkyl–substituted allenoates (2a–2m) was due to
the enhanced acidity of its β′-protons, thereby facilitating the conversion of the
phosphonium enoate to the vinylogous ylide and its subsequent addition at the β′-carbon
atom (see the mechanistic discussion below).
On the basis of the reported mechanistic studies of nucleophilic phosphine-catalyzed
reactions,2 Scheme 3 presents plausible pathways for the reactions of the azomethine imines
1 and the allenoates 2. Upon conjugate addition of PBu3 to the allenoate 2, the zwitterion A
is formed. Because of steric crowding at its α-carbon atom, the β-phosphonium enoate A
undergoes addition at its β-carbon atom to form the amide B. A second conjugate addition of
the amide to the β-phosphonium enoate motif of intermediate B accomplishes the [3 + 2]
cyclization. The thus-formed β-phosphonium enoate C undergoes facile β-elimination to
regenerate the catalyst, forming the final tetrahydropyrazolopyrazolone product 3. On the
other hand, the carboxylic ester substituent at the β′-carbon atom of the allenoate 2n
facilitates the conversion of the phosphonium enoate A to the vinylogous ylide D,32 which
then adds to the azomethine imine 1 to form the intermediate E. Unlike the 5-exo cyclization
of the intermediate B to form C, the 6-endo cyclization of the amide E to form F is less
efficient when PBu3 is the catalyst (23% isolated yield of the
tetrahydropyrazolopyridazinone 4); in this case, the intermediate E isomerizes into another
amide species H.33 The ylide I is formed from the 7-endo cyclization of H; it then expels the
catalyst PBu3 through the ylide-to-enoate conversion to furnish the
tetrahydropyrazolodiazepinone 5. When PMe3 is employed as the catalyst, however,
conjugate addition of the amide to the β-phosphonium enoates in B and E is the major
reaction pathways for the allenoate 2n, due to decreased steric congestion at the β-carbon
atom.
With regard to the high E-selectivity for the exocyclic double bond of
tetrahydropyrazolopyrazolone 3, Density Functional Calculations at the M06/6-31G** level
of theory showed a strong interaction between the phosphorous atom and the carbonyl of the
β-phosphonium enoate, most likely of electrostatic nature. This electrostatic interaction is
thought to be key for the strereochemical outcome of the reaction (Scheme 4). Structurally,
the phosphonium group points away from the bicycle, as a consequence of the relatively
puckered heterobicycle and the pyramidalized carbon bearing the phosphonium enoate. This
structural motif causes the phosphonium group to depart away from the bicyclic structure,
thus favoring rotation of the carbonyl also away from the rest of the molecule. Therefore, it
is anticipated that the magnitude of the electrostatic interaction should have an impact on the
stereochemistry of the reaction. This lower perceived stereoselectivity (for the E isomer)
could be eroded with increasing phosphine bulkiness. To further analyze the dominant
stereodirecting effects in the elimination reaction, we performed relaxed coordinate scans
for the phosphine-carbon elongation with PMe3 and (R)-II. Our calculations show that it is a
combination of factors that lead to the low stereoselectivity when (R)-II is used. The
bulkiness provided by the cyclohexyl group, the axial chirality, and the high torque of the
benzyl groups in (R)-II, all impose a rigid chiral pocket that changes the orientation of the
departure of the leaving phosphine group. In addition, we believe that the bulkier (R)-II may
not allow for a P-O(=C) interaction as strong as that with less bulky phosphines, as a
consequence of the slightly longer interatomic distance and overall structural rigidity. Both,
the weaker electrostatic interaction, and the different departing orientation do not favor the
rotation of the enoate in any direction, leading to low stereoselectivities. This can be
observed by the differences in the dihedral angle of the enoate group at the transition state
for elimination (Scheme 4). The elimination transition state for PMe3 as phosphine is a
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much later transition state, where the dihedral angle is ~30°, while for (R)-II, it is an early
transition state with an enoate dihedral angle of ~10°.
Encouraged by the successful incorporation of the azomethine ylides 1 as annulation
reaction partners in the phosphine catalysis of α-substituted allenoates, we launched an
investigation into the reaction of ethyl 2,3-butadienoate (2o) with the azomethine imine 1a.
Our anticipation was that the allenoate 2o would serve as a two- or three-carbon component
for [3 + 2] or [3 + 3] annulation, respectively, with the azomethine ylides 1. In the event,
treatment of the allenoate 2o with the azomethine imine 1a in DCM at room temperature for
24 h under the influence of 20 mol % of PBu3 afforded the tetrahydropyrazolopyrazolone
3ao and the tetrahydropyrazolopyridazinone 6 in 45 and 36% yields, respectively, along
with an unknown product (Table 5, entry 6). We used X-ray crystallography to establish the
structures of the [3 + 2] adduct 3ao and the [3 + 3] adduct 6. Although the reaction provided
a mixture of products, each compound exhibited exquisite stereoselectivity; 3ao was
obtained exclusively in the E isomeric form and 6 as a single trans diastereoisomer. The
annulations producing the adducts 3ao and 6 were apparently initiated by the additions at the
β-and α-carbon atoms, respectively, of the allenoate 2o (see Scheme 3 and the mechanistic
rationale below). In an attempt to improve the yield and chemoselectivity, we tested the
effects of other phosphines (Table 5). Using PPh3 instead of PBu3 as the catalyst caused the
reaction to proceed much more sluggishly, giving the cyclized products in poor yields, with
the [3 + 3] adduct 6 as the major product (entry 2). When we used the more-nucleophilic
phosphines EtPPh2, MePPh2, and Me2PPh as catalysts, we obtained the [3 + 2]
cycloaddition product 3ao as the major product with improved yields (27, 53, and 69%,
respectively) and relatively smaller amounts (5, 2, and 15%, respectively) of the [3 + 3]
product (entries 3–5). Trimethylphosphine performed the best in terms of its 3ao/6
selectivity, with a 62% yield of the tetrahydropyrazolopyrazolone 3ao and a negligible
amount (3%) of 6 (entry 7). Notably, HMPT facilitated the reaction of the azomethine ylide
1a and the allenoate 2o, albeit in low efficiency (entry 8). One peculiar observation was that
an additional byproduct, which we isolated in less than 5% when using either PMe3 or PBu3,
was isolated in almost 10% yield when using HMPT as the catalyst (vide infra).
Evidently, the product 3ao was obtained via addition at the γ-carbon atom of the allenoate
2o while 6ao was produced via addition at the α-carbon atom. Consequently, we anticipated
that γ-substituted allenoates would provide compounds 6 exclusively. Screening of the
reaction conditions and substrates revealed that γ-substituted allenoates, namely γ-methyl,
ethyl, isopropyl, tert-butyl, and phenyl allenoates, underwent annulations with the
azomethine imine 1a under mild conditions with tolerable conversions. Nevertheless, these
annulations appeared to proceed through at least two pathways, providing several spots on
the TLC plates. With the γ-methyl and γ-phenyl allenoates as substrates, we could not
isolate the pure target products because the reaction mixtures were too messy. From the
γethyl, γ-isopropyl, and γ-tert-butyl allenoates 2p–2r, we isolated the [3 + 3] annulation
products 6′ as major products in moderate yields (Scheme 5).
Scheme 3 presents a mechanistic rationale for the [3 + 2] annulation of the azomethine imine
1a and the allenoate 2o to form 3ao. The [3 + 3] annulation was initiated through the
formation of the β-phosphonium enoate intermediate J (Scheme 6). Addition of the
zwitterion J to the iminium unit in 1 produced the phosphonium amide K. The 6-endo
cyclization of K furnished the ylide L, which eliminated the phosphine after conversion to
the β-phosphonium ester M to yield the tetrahydropyrazolopyridazinone 6′. When the
allenoate 2o was the substrate, however, the conjugated enoate 6′ was not isolated;
presumably, it isomerized into the enoate 6 because of the more acidic nature of the γ-proton
when R1 was a hydrogen atom. This reaction marks the first example of a [3 + 3] annulation
in which all three unsaturated carbon atoms of an allene are incorporated into the six-
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membered-ring product and suggests the future development of other [3 + 3] annulations
between 1,3-dipoles and allenoates.
Next, we studied in further detail the unidentified byproduct generated from the above-
mentioned reaction of ethyl 2,3-butadienoate (2o) and the azomethine imine 1a. To our
delight, using a combination of NMR spectroscopy and X-ray crystallography, we
determined the structures of these unknown products to be an equilibrating mixture of
unexpected [3 + 2 + 3] products: the 1-oxo-2,3,5,6-tetrahydro-1H-pyrazolo[1,2-a]
[1,2]diazocine derivative 7 and the 1-oxo-2,3,5,10-tetrahydro-1H-pyrazolo[1,2-a]
[1,2]diazocine derivative 8 (Scheme 7). In this particular reaction, a trimeric zwitterionic
intermediate, formed from two molecules of ethyl 2,3-butadienoate (2o) and a phosphine,
presumably acted as a 1,5-dipole34 synthon to react with the azomethine imine, providing
the [3 + 2 + 3] cycloaddition products. To the best of our knowledge, this reaction is the first
example of this trimeric 1,5-dipole being captured in a phosphine-catalyzed intermolecular
annulation of allenoates and electrophiles.5a, 35 This intriguing finding prompted us to
further investigate this new reaction modality of the allenoate 2o under nucleophilic
phosphine catalysis conditions. Although the literature is replete with examples of the
incorporation of two molecules of alkenes, acetylenes, and allenes under transition-metal
catalysis conditions36, these incidents are relatively rare in the realm of organocatalysis.37
We varied the reaction conditions in an attempt to improve the yields of the [3 + 2 + 3]
adducts. An initial survey of the reaction parameters revealed that the highest [3 + 2 + 3]
product yield resulted when we conducted the reaction in DCM/benzene (4:1) at 0 °C. We
employed this mixed solvent because DCM aided the dissolution of the azomethine imine
and benzene favored the formation of the trimeric zwitterionic intermediate from a
phosphine and two ethyl 2,3-butadienoate (2o) units, as observed by Lu.5a Varying the
solvent or increasing the reaction temperature was deleterious to the reaction selectivity—
specifically, it increased the amounts of the [3 + 2] and [3 + 3] cycloaddition products. In the
mixed solvent (4:1 DCM/benzene) at 0 °C, the reaction between the azomethine imine 1a
and the allenoate 2o displayed behavior somewhat distinct from that in DCM at room
temperature (cf. Tables 5 and 6). For instance, the use of PPh3 as the catalyst at 0 °C in 4:1
DCM/benzene produced the [3 + 2] adduct as the major product (Table 6, entry 1). The
trialkylphosphines PBu3 and PMe3 exhibited similar reaction profiles (entries 2 and 3).
Dimethylphenylphosphine consistently provided the highest efficiency for the formation of
the tetrahydropyrazolopyrazolone 3ao (entry 4); the overall reaction yield increased to 99%,
of which 29% corresponded to the tetrahydropyrazolodiazocinone products 7a/8a. The use
of HMPT as catalyst produced even more of the [3 + 2 + 3] product, but the overall mass
recovery was lower (entry 5). This observation prompted us to test the effects of tris(sec-
alkyl)phosphines (entries 6 and 7). We found that PCy3 was the most effective catalyst,
affording the [3 + 2 + 3] adduct 7a/8a as the major product in 65% yield after 120 h (entry
8). Triisopropylphosphine also produced the tetrahydrodiazocine 7a/8a as the major product,
but with lower efficiency. Tris(tert-butyl)phosphine displayed barely any reactivity at this
low temperature, presumably because of steric hindrance; TLC revealed almost no
cycloaddition products.
Under these optimized reaction conditions (in 4:1 DCM/benzene at 0 °C with 20 mol % of
PCy3), we investigated the reactions of a variety of azomethine imines 1 with the allenoate
2o (Table 7). When the azomethine imines 1 were derived from benzaldehydes featuring
electron-donating or -withdrawing substituents at the para position, the reactions proceeded
smoothly to afford the tetrahydropyrazolodiazocinones 7/8 in moderate to good yields
(Table 7, entries 1–8); thus, electron-withdrawing and -donating groups at the para position
provided similar reaction efficiencies. In contrast, meta and ortho substitution favored
electron-withdrawing substituents (entries 9–16). In particular, ortho-halogen–substituted
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aryl groups produced the bicyclic products 7/8 in excellent yields (88–92%; entries 13–15).
The 2-naphthaldehyde–derived azomethine imine 1m was also a viable substrate (entry 17).
Scheme 8 provides a mechanistic proposal for this unprecedented cyclization reaction. The
key event is the formation of the trimeric zwitterionic intermediate N, which is then captured
in situ by the azomethine imine 1. The trimeric zwitterionic intermediate N is generated via
the conjugate addition of the β-phosphonium dienloate J to another molecule of the
allenoate 2o. The self-cycloaddition of the allenoate 2o to form P under phosphine catalysis
has been reported previously, by Lu in 1995.5a Here, for the first time, we have realized the
intermolecular cycloaddition of the trimeric intermediate N with the azomethine imine. In a
scenario where the fewest zwitterionic intermediates are involved,38 the intermediate N adds
to the azomethine imine 1 to form the intermediate Q. The 8-endo cyclization of Q produces
the ylide R. Well-established proton transfers and subsequent β-elimination of the phosphine
leads to formation of the tetrahydropyrazolodiazocinone product S. It appears that the cross-
conjugated exomethylene group in compound S isomerizes into the endocyclic double bond
to give the tetrahydropyrazolodiazocinone 8. In turn, we isolated compound 8 as an
equilibrating mixture with its tautomer 7.
To compare the relative ground state energies of the tetrahydropyrazolodiazocinones S (R =
phenyl), 7b, and 8b, we studied these three molecules computationally using density
functional theory (DFT) with the M06 functional, a hybrid meta-GGA functional that can be
a good choice for main-group thermochemistry.39 Given the conformer-rich landscape of the
our tetrahydropyrazolodiazocinones, we used the M06/6-31G** level of theory to perform a
conformational study, focusing on the positioning of the ring substituents and inversion of
the sp3-hybridized nitrogen atom. We further minimized at least two of the lowest-energy
conformers for each isomer (S, 7b, 8b) using finer grids and calculated the analytic Hessian
for each minimum. Electronic energies were calculated using the M06 functional and the
correlation-consistent polarized triple-ζ basis set cc-pVTZ++40 as implemented in Jaguar
7.6.110.41 For S, 7b, and 8b, the computed relative ground state free energies (ΔG;
including zero-point, solvation for DCM, and thermodynamic corrections to the free energy
at 298 K) at the M06/cc-pVTZ++ level were 4.1, 0.8, and 0.0 kcal/mol, respectively; thus,
isomerization of the intermediate S to the product 8b is thermodynamically favored and
compounds 8b and 7b would be in equilibrium at ambient temperature, as observed
experimentally (Table 7, entry 1).
In determining the structures of the [3 + 2 + 3] annulation products, all of our 1H and 13C
NMR spectra, recorded in CDCl3 at room temperature, indicated that the products existed as
mixtures of the tautomers 7 and 8 in solution, with 8 as the major isomer. To further study
the interconversion of compound 7 and its tautomer 8 in solution, we recorded 1H NMR
spectra of the 7a/8a and 7h/8h pairs in various deuterated solvents and at various
temperatures—making some interesting observations. For the 7a/8a pair, 8a was the major
isomer in either CDCl3 or CD2Cl2 at room temperature; the ratio of 7a to 8a was
approximately 1:4. Even in CD2Cl2 at −80 °C, the ratio of 7a to 8a remained unchanged,
although the two signals of the aromatic protons broadened as the temperature increased.42
Relative to the behavior of the 7a/8a pair, the 7h/8h equilibrium was very sensitive to the
solvent and temperature. In CDCl3 at room temperature, 8h was the major isomer and the
ratio of 8h to 7h was 71:29. In contrast, in CD2Cl2 at room temperature, 7h existed as the
sole isomer. When we decreased the temperature from room temperature to −20 °C, the two
signals of the aromatic protons each resolved from one broad peak to two distinct sharp
peaks. More interestingly, in CDCl3 at 0 or −20 °C, the mixture of the two tautomers 7h and
8h completely converged into 7h.42 These observations are consistent with the crystal
growth behavior. When we left the 7h/8h compound pair in DCM/MeOH, we isolated single
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crystals of 7h exclusively. From the mixture of compounds 7a and 8a, we grew single
crystals of the single tautomer 8a from DCM/hexane or DCM/MeOH.
The fused pyrazolidinone heterocycles, arising from the phosphine-catalyzed annulations of
azomethine imines with allenoates, can be transformed into other useful compounds. For
example, SmI2 selectively reduced the exocyclic double bond to provide pyrazolopyrazolone
9 as a single diastereoisomer43,44 while treatment with NaBH4 in EtOH furnished the ring-
opened product 10 as a mixture of diastereoisomers (Scheme 9). The
dihydropyrazolopyrazolone 11, obtained through the CuBr/TBHP oxidation,45 should be a
useful precursor for further functionalization through cross-coupling reactions. Treatment of
the tetrahydrodiazocine 7b/8b with SmI2 reduced the enamine double bond selectively to
provide the dihydrodiazocine 12 in 73% isolated yield.43,44
Conclusion
We have investigated the phosphine-catalyzed [3 + 2], [3 + 3], [4 + 3], and [3 + 2 + 3]
annulations of azomethine imines with allenoates. These cyclization reactions are
operationally simple and proceed smoothly under very mild reaction conditions, providing a
broad range of fused pyrazolidinone heterocycles in moderate to excellent yields. The
positive characteristics of this protocol—including the production of a diverse range of
dinitrogen-fused bicycles and the ready preparation of azomethine imine substrates—
suggest that these reactions might have extensive applicability in organic synthesis. Notably,
we captured a trimeric zwitterionic intermediate, formed from two molecules of ethyl 2,3-
butadienoate and a molecule of a phosphine, that acted as a 1,5-dipole in the cycloaddition
reaction, leading to [3 + 2 + 3] adducts. The incorporation of two molecules of allenoates
into cycloaddition products is a new application for this versatile class of molecules under
phosphine catalysis conditions. In addition, we investigated, both spectroscopically and
computationally, the unique tautomerization behavior of the tetrahydropyrazolodiazocinone
products. Studies to address the further applications of azomethine imines in nucleophilic
phosphine catalysis and the development of asymmetric variants of these annulations, as
well as their use in the synthesis of biologically relevant molecules, are ongoing in our
laboratories.
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Figure 1.
Selected examples of biologically active dinitrogen-fused heterocycles.
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Scheme 1.
Phosphine-Catalyzed [3 + N] Cyclizations of Azomethine Imines with Allenoates
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Scheme 2.
Phosphine-Catalyzed Annulations of the Azomethine Imine 1a with the Allenoate 2n
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Scheme 3.
Mechanisms for the Azomethine Imine–Allenoate [3 + 2], [3 + 3], and [4 + 3] Annulations
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Scheme 4.
Computational study of the stereochemical preference of PMe3 and (R)-II.
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Scheme 5.
PBu3-Catalyzed [3 + 3] Annulations of the Azomethine Imine 1a with γ-Substituted
Allenoates
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Scheme 6.
Mechanistic Rationale for the Formation of Compounds 6 and 6′
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Scheme 7.
Phosphine-Catalyzed [3 + 2 + 3] Annulation of the Azomethine Imine 1 and the Allenoate
2o
Na et al. Page 21
J Am Chem Soc. Author manuscript; available in PMC 2012 August 31.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Scheme 8.
Mechanism for the [3 + 2 + 3] Cycloadditions of the Azomethine Imines 1 and the Allenoate
2o
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Scheme 9.
Reactions of the Tetrahydropyrazolopyrazolone 3ba and the Tetrahydropyrazolodiazocinone
7b
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Table 1
Phosphine-Catalyzed [3 + 2] Cycloadditions of the Azomethine Imine 1a with the Allenoate 2aa
entry PR3 time (h) yield (%)b
1 c - 48 0
2 PPh3 24 5
3 MePPh2 24 24
4 Me2PPh 24 53
5 PBu3 14 88
6 PMe3 12 92
7 HMPT 24 0
a
1.2 equiv of allenoate was used.
b
Isolated yield.
c
Without phosphine catalyst.
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Table 2
Chiral Phosphine-Catalyzed [3 + 2] Cycloadditions of the Azomethine Imine 1b with the Allenoate 2aa
entry catalyst time (h) yield (%)b ee (%)c
1 (R, R)-DiPAMP 120 <5 n.d.d
2 (R)-BINAP 120 <5 n.d.
3 (+)-Me-PuPhos 120 <5 n.d.
4 (+)-Et-BPE 120 19 6
5 (+)-TangPhos 120 <5 n.d.
6 (R)-Et-BINEPHINE 120 <5 n.d.
7 (R)-t-Bu-BINEPHINE 120 <5 n.d.
8 (S, S)-FerroPHANE 120 <5 n.d.
9 (R)-I 48 8 93
10 (R)-II 48 56e 89
a
Reactions were conducted with 0.1 mmol of 1b and 1.5 equiv of allenoate in 1 mL of DCM. The absolute configuration of the major enantiomer
has not been determined.
b
Isolated yield.
c
Enantiomeric excess was determined through HPLC analysis on a chiral stationary phase.
d
Not determined.
e
The Z isomer was isolated in 18% yield.
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Table 3
PBu3-Catalyzed [3 + 2] Cycloadditions of Azomethine Imines 1 with the Allenoate 2aa
entry R time (h) product yield (%)b
1 Ph (1b) 24 3ba 97
2 4-MeC6H4 (1c) 24 3ca 85
3 4-i-PrC6H4 (1d) 24 3da 89
4 4-OMeC6H4 (1e) 30 3ea 77
5 4-FC6H4 (1f) 24 3fa 91
6 4-ClC6H4 (1g) 20 3ga 93
7 4-BrC6H4 (1h) 20 3ha 97
8 4-CNC6H4 (1i) 12 3ia 87
9 4-CF3C6H4 (1j) 24 3ja 98
10 3-NO2C6H4 (1k) 24 3ka 97
11 2-NO2C6H4 (1l) 24 3la 94
12c 2-MeC6H4 (1m) 48 3ma 70
13c 2-PhC6H4 (1n) 48 3na 50
14c 1-naphthyl (1o) 48 3oa 57
15 2-naphthyl (1p) 24 3pa 96
16 4-pyridyl (1q) 20 3qa 86
17 2-furanyl (1r) 20 3ra 99
18 cyclohexyl (1s) 36 3sa 55
19 n-Bu (1t) 72 3ta 41
20 i-Pr (1u) 72 3ua 48
a
1.2 equiv of allenoate was used.
b
Isolated yield.
c
The reaction was run at 40 °C.
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Table 5
Phosphine-Catalyzed Annulations of the Azomethine Imine 1a with Ethyl 2,3-Butadienoate (2o)a
entry PR3 time (h) 3ao
b
yield (%)c
6b
yield (%)c
1 d – 48 0 0
2 PPh3 24 8 19
3 EtPPh2 24 27 5
4 MePPh2 24 53 2
5 Me2PPh 24 69 15
6 PBu3 24 45 36
7 PMe3 12 62 3
8 HMPT 24 15 22
a
1.2 equiv of allenoate was used.
b
The structure of this compound was verified through single-crystal X-ray analysis.
c
Isolated yield.
d
Without phosphine catalyst.
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Table 6
Phosphine-Catalyzed [3 + 2 + 3] Annulations of the Azomethine Imine 1a and the Allenoate 2oa
entry PR3
3ao
yield (%)b
6
yield (%)b
7a/8ac,d
yield (%)b
1 PPh3 29 19 <2
2 PBu3 26 12 4
3 PMe3 51 3 6
4 PMe2Ph 65 5 29
5 HMPT 50 4 32
6 P(i-Pr)3 24 10 26
7 PCy3 5 2 61
8e PCy3 7 2 65f
a
2.4 equiv of allenoate was used.
b
Isolated yield.
c
The structure of this compound was verified through single-crystal X-ray analysis.
d
The 7a:8a ratios were not determined, except the case in entry 8.
e
The reaction was run for 120 h.
f
The 7a:8a ratio was 19:81, based on integration of signals in the 1H NMR spectrum recorded in CDCl3.
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Table 7
Phosphine-Catalyzed [3 + 2 + 3] Cycloadditions of the Azomethine Imines 1 with the Allenoate 2oa
entry R product yield (%)b ratio of 7:8c
1 Ph (1b) 7b + 8b 81 34:66
2 4-MeC6H4 (1c) 7c + 8c 64 39:61
3 4-i-PrC6H4 (1d) 7d + 8d 67 42:58
4 4-OMeC6H4 (1e) 7e + 8e 76 44:56
5 4-FC6H4 (1f) 7f + 8f 68 27:73
6 4-ClC6H4 (1g) 7g + 8g 63 37:63
7 4-BrC6H4 (1h) 7hd + 8h 77 29:71
8 4-CNC6H4 (1i) 7id + 8i 51 21:79
9 3-NO2C6H4 (1k) 7k + 8k 77 17:83
10 3-FC6H4 (1v) 7v + 8v 79 25:75
11 3-ClC6H4 (1w) 7w + 8w 82 24:76
12 3-BrC6H4 (1x) 7x + 8x 75 22:78
13 2-BrC6H4 (1y) 7y + 8y 92 28:72
14 2-ClC6H4 (1z) 7z + 8z 90 24:76
15 2-FC6H4 (1zz) 7zz + 8zz 88 25:75
16 2-NO2C6H4 (1l) 7l + 8l 73 9:91
17 2-naphthyl (1p) 7p + 8p 76 32:68
a
2.4 equiv of allenoate was used.
b
Isolated yield.
c
Based on integration of signals in the 1H NMR spectrum recorded in CDCl3; the solvent had a very strong effect on the ratio.
d
The structure of this compound was verified through single-crystal X-ray analysis.
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